跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 335 条关于
“BF-RhodoLED”
全部
335
临床试验
43
药物
36
机构
234
资讯
22
去年
Biofrontera's Ameluz Demonstrates High Efficacy in Phase III sBCC Trial
去年
Biofrontera Announces Database Lock for Phase 3 sBCC Study of Ameluz®-PDT
去年
Biofrontera's Ameluz Demonstrates Success in Phase III sBCC Trial, Stock Surges
去年
Biofrontera Inc. Negotiates Strategic Partnership Changes with German Parent Company
4天前
FDA Approves Biofrontera's Ameluz Red-Light PDT for Superficial Basal Cell Carcinoma
去年
Ameluz-PDT Demonstrates High Lesion Clearance in Superficial Basal Cell Carcinoma Phase 3 Trial
去年
FDA Decisions Loom for Biofrontera, BMS, and Zealand Pharma
9个月前
Biofrontera Submits FDA Application for Ameluz-PDT in Superficial Basal Cell Carcinoma Treatment
去年
Ameluz Demonstrates High Efficacy in Phase 3 Trial for Superficial Basal Cell Carcinoma
去年
Biofrontera Completes Phase 2b Trial of Ameluz for Moderate to Severe Acne Treatment
第 1 页,共 3 页
上一页
下一页